---
title: "Antimicrobial Medications"
tags: [medications, antibiotics, infectious-disease]
sidebar: ccms_medications_sidebar
permalink: /medications/antimicrobial-medications.html
summary: Comprehensive guide to antimicrobial medications including antibiotics, antifungals, and antivirals
---

# Antimicrobial Medications

Comprehensive reference for antimicrobial medications including antibiotics, antifungals, and antivirals with dosing, spectrum, and resistance patterns.

## Beta-Lactam Antibiotics

### Penicillins
**Mechanism**: Inhibit cell wall synthesis by binding to penicillin-binding proteins

| Medication | Dose | Frequency | Spectrum | Indications |
|------------|------|-----------|---------|-------------|
| Penicillin G | 2-4 MU | Q4-6h | Gram-positive | Strep infections |
| Amoxicillin | 500mg | TID | Gram-positive/negative | Respiratory, UTI |
| Ampicillin | 1-2g | Q6h | Gram-positive/negative | Meningitis, endocarditis |
| Piperacillin-tazobactam | 4.5g | Q8h | Broad spectrum | Hospital infections |

**Side Effects**: Allergic reactions, diarrhea, C. difficile
**Resistance**: Beta-lactamase production

### Cephalosporins
**Mechanism**: Similar to penicillins, more resistant to beta-lactamases

| Generation | Medication | Dose | Spectrum | Indications |
|------------|------------|------|---------|-------------|
| 1st | Cephalexin | 500mg QID | Gram-positive | Skin infections |
| 2nd | Cefuroxime | 750mg Q8h | Gram-positive/negative | Respiratory |
| 3rd | Ceftriaxone | 1-2g Q24h | Gram-negative | Meningitis, pneumonia |
| 4th | Cefepime | 2g Q12h | Broad spectrum | Neutropenic fever |

**Cross-reactivity**: 5-10% with penicillin allergy
**Monitoring**: Renal function, bleeding risk

## Fluoroquinolones
**Mechanism**: Inhibit DNA gyrase and topoisomerase IV

| Medication | Dose | Frequency | Spectrum | Indications |
|------------|------|-----------|---------|-------------|
| Ciprofloxacin | 500mg | BID | Gram-negative | UTI, respiratory |
| Levofloxacin | 500mg | Daily | Gram-positive/negative | Pneumonia, UTI |
| Moxifloxacin | 400mg | Daily | Respiratory pathogens | CAP, sinusitis |

**Side Effects**: Tendon rupture, QT prolongation, CNS effects
**Contraindications**: Pregnancy, children <18 years
**Resistance**: Increasing resistance in E. coli

## Macrolides
**Mechanism**: Bind to 50S ribosomal subunit, inhibit protein synthesis

| Medication | Dose | Frequency | Spectrum | Indications |
|------------|------|-----------|---------|-------------|
| Azithromycin | 500mg day 1, then 250mg | Daily × 5 | Atypical pathogens | CAP, STI |
| Clarithromycin | 500mg | BID | Respiratory pathogens | H. pylori, CAP |
| Erythromycin | 500mg | QID | Gram-positive | Penicillin allergy |

**Side Effects**: GI upset, QT prolongation, hepatotoxicity
**Drug Interactions**: CYP3A4 inhibitors, warfarin

## Glycopeptides
**Mechanism**: Bind to D-Ala-D-Ala terminus, inhibit cell wall synthesis

### Vancomycin
- **Dose**: 15-20 mg/kg Q8-12h (adjust for CrCl)
- **Target Trough**: 15-20 mg/L (serious infections)
- **Spectrum**: Gram-positive only
- **Indications**: MRSA, C. difficile colitis
- **Monitoring**: Trough levels, CrCl, hearing

### Daptomycin
- **Dose**: 4-6 mg/kg Q24h
- **Spectrum**: Gram-positive only
- **Indications**: MRSA bacteremia, endocarditis
- **Side Effects**: CPK elevation, myopathy

## Antifungal Agents

### Azoles
**Mechanism**: Inhibit ergosterol synthesis

| Medication | Dose | Indications | Side Effects |
|------------|------|-------------|--------------|
| Fluconazole | 200-400mg daily | Candidiasis, cryptococcosis | Hepatotoxicity |
| Itraconazole | 200mg BID | Aspergillosis, histoplasmosis | CHF, hepatotoxicity |
| Voriconazole | 200mg BID | Aspergillosis, candidiasis | Visual disturbances |

**Drug Interactions**: CYP3A4 inhibitors/inducers
**Monitoring**: LFTs, drug levels

### Echinocandins
**Mechanism**: Inhibit beta-glucan synthesis

| Medication | Dose | Indications | Advantages |
|------------|------|-------------|------------|
| Caspofungin | 70mg load, 50mg daily | Candidiasis, aspergillosis | Broad spectrum |
| Micafungin | 100mg daily | Candidiasis | Well-tolerated |
| Anidulafungin | 200mg load, 100mg daily | Candidiasis | Long half-life |

**Side Effects**: Infusion reactions, hepatotoxicity
**Spectrum**: Candida, Aspergillus

## Antiviral Agents

### Acyclovir Family
**Mechanism**: Inhibit viral DNA polymerase

| Medication | Dose | Indications | Side Effects |
|------------|------|-------------|--------------|
| Acyclovir | 400mg TID | HSV, VZV | Nephrotoxicity |
| Valacyclovir | 1g TID | HSV, VZV | Headache, nausea |
| Famciclovir | 500mg TID | HSV, VZV | Headache, diarrhea |

**Monitoring**: Renal function, hydration
**Resistance**: Rare but increasing

### Oseltamivir
- **Dose**: 75mg BID × 5 days
- **Indications**: Influenza A/B
- **Timing**: Start within 48 hours of symptoms
- **Side Effects**: Nausea, vomiting, neuropsychiatric events

## Resistance Patterns

### Gram-Positive Resistance
- **MRSA**: Vancomycin, daptomycin, linezolid
- **VRE**: Linezolid, daptomycin, tigecycline
- **Penicillin-resistant S. pneumoniae**: Ceftriaxone, vancomycin

### Gram-Negative Resistance
- **ESBL-producing E. coli**: Carbapenems, tigecycline
- **CRE**: Polymyxins, tigecycline, aminoglycosides
- **MDR P. aeruginosa**: Colistin, ceftolozane-tazobactam

## Antimicrobial Stewardship

### Principles
- **Right Drug**: Appropriate spectrum, resistance patterns
- **Right Dose**: Optimize pharmacokinetics/pharmacodynamics
- **Right Duration**: Shortest effective course
- **Right Route**: Oral when possible

### De-escalation Strategies
1. **Day 1-3**: Broad-spectrum empiric therapy
2. **Day 3-5**: Narrow spectrum based on cultures
3. **Day 5-7**: Oral conversion if appropriate
4. **Day 7-10**: Discharge planning

## Monitoring and Safety

### Required Monitoring
- **Renal Function**: Vancomycin, aminoglycosides
- **Hepatic Function**: Azoles, linezolid
- **Drug Levels**: Vancomycin, aminoglycosides
- **QT Interval**: Fluoroquinolones, azoles

### Adverse Events
- **Allergic Reactions**: Rash, anaphylaxis
- **C. difficile**: Diarrhea, pseudomembranous colitis
- **Superinfection**: Fungal, resistant bacterial
- **Organ Toxicity**: Nephrotoxicity, hepatotoxicity
